Enterprise Insurance v Flowers: Privy Council refuses £32.3m credit to dishonest director

Board restores full compensation, rejecting deduction for parent company capital injections.
The Privy Council has held that a dishonest former managing director of a collapsed Gibraltar insurer cannot reduce his liability by £32.3 million on the basis that the insurer's parent company injected capital into it during the period of his wrongdoing.
In Enterprise Insurance Company plc (In Liquidation) v Flowers [2026] UKPC 40, Lord Reed, giving the judgement of the Board, allowed the liquidators' appeal against the Court of Appeal for Gibraltar and dismissed a cross-appeal concerning insurance policies written for investors in the Icebreaker tax avoidance scheme.
The triangular structure
Enterprise Insurance Company plc (EIC) traded from 2003 until its provisional liquidation in 2016, with a deficit estimated at around £200 million. It sat within a group that ostensibly operated a "triangular model": EIC paid a sister service company, EIG, which paid dividends to the holding company, EHL, which in turn subscribed for new shares in EIC to bolster its regulatory solvency margin.
The trial judge found that EIC's payments to EIG were for services never provided and that Mr Flowers was dishonestly involved. EIG paid £12.3 million to EHL's shareholders on fictitious invoices, half of it to Mr Flowers. EHL subscribed £32.3 million for EIC shares, £8.3 million derived from EIG dividends and £24 million borrowed through bonds. EHL's other directors were found to have acted in good faith.
The Court of Appeal held that the capital injections were closely linked to the wrongdoing, applying Tiuta International Ltd v De Villiers Surveyors Ltd, and ordered that credit be given for the full £32.3 million.
No benefit established
The Board approached the issue in two stages: whether EIC benefited at all and, if so, whether the benefit was deductible. Damages compare the claimant's actual position with its position absent the breach, and the evidential burden lies on the defendant.
The issue of new shares to an existing sole shareholder did not, in reality, prevent the payments being a benefit. But the trial judge's findings showed the injections allowed EIC to "stagger on" largely unprofitably, writing more business without adequate reserves while further sums were extracted. The fresh capital was a disbenefit, and Mr Flowers had not proved otherwise.
Deductibility
Lord Reed added that any benefit would not have been deductible in any event. The bond-funded £24 million was an independent response by EHL. More fundamentally, EHL intended to support its subsidiary, not to release a dishonest director from liability. By analogy with gratuitous third-party payments, crediting the wrongdoer would be unjust, unreasonable and contrary to public policy. The same result followed for equitable compensation.
The Board cautioned against treating Lord Sumption's "broadly speaking" remarks on collateral benefits in Swynson and Tiuta as a comprehensive test, since benefits received in consequence of loss turn on their character rather than causation.
Icebreaker cross-appeal
Mr Flowers argued that EIC was never at risk under the Icebreaker policies, relying on clause 11.4, which excluded liability where the insured and the LLP had "colluded in an attempt to engineer the failure of the LLP". Investors had no control over the scheme, and there was no misrepresentation. Construing the clause so as to exclude every investor would negate the policy's purpose.
The argument that the policies were void as contrary to public policy also failed. Tax avoidance schemes are not unlawful, and nothing in Ramsay, the general anti-abuse rule or targeted anti-avoidance rules affects the validity of such arrangements. The FSCS permission decisions relied on had no precedential authority.
Nigel Jones KC, Sarah McCann KC, Charles Simpson and Sebastian Triay (Triay Lawyers) for EIC; Mr Flowers appeared in person.
.png&w=3840&q=60)










